Advertisement
Advertisement
June 11, 2026
Ventiv Scientific’s V-Pulse Mechanical Thrombectomy System Used in FIH Procedures
KEY TAKEAWAYS
- First-in-human procedures were completed with Ventiv Scientific’s V-Pulse mechanical thrombectomy system.
- The platform is designed to provide real-time control of aspiration force at the catheter tip during thrombus removal procedures.
- Initial clinical experience suggested effective clot extraction with visual confirmation of thrombus capture through an integrated filtration system.
June 11, 2026—Ventiv Scientific announced the completion of the first-in-human (FIH) clinical procedures with its V-Pulse mechanical thrombectomy system. The investigational thrombectomy platform was developed to remove blood clots from the peripheral vasculature.
According to the company, the V-Pulse system is designed to provide real-time control over aspiration force at the catheter tip. It enables clinicians to rapidly initiate, stop, increase, or decrease aspiration while potentially minimizing catheter clogging and reducing procedural blood loss.
In the Ventiv Scientific press release, Mahmood Razavi, MD, with St. Joseph Heart & Vascular Center in Orange, California, commented on the FIH use of the device.
“The V-Pulse system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology,” stated Dr. Razavi. “In our initial experience, the device demonstrated excellent control and procedural efficiency. Effective clot removal is critical for patients suffering from venous and arterial thrombotic disease, where delayed treatment can lead to serious complications.”
Advertisement
Advertisement
